Idiopathic pulmonary fibrosis/progressive pulmonary fibrosis

Clinical trials for Idiopathic pulmonary fibrosis/progressive pulmonary fibrosis explained in plain language.

Never miss a new study

Get alerted when new Idiopathic pulmonary fibrosis/progressive pulmonary fibrosis trials appear

Sign up with your email to follow new studies for Idiopathic pulmonary fibrosis/progressive pulmonary fibrosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New oral drug HRS-9813 takes first step against scarred lungs

Disease control Completed

This Phase 1 trial tests the safety and how the body handles HRS-9813, an experimental oral drug for idiopathic pulmonary fibrosis (a lung-scarring disease). Healthy volunteers aged 18-45 take multiple doses to measure side effects and drug levels in the blood. The study does not…

Matched conditions: IDIOPATHIC PULMONARY FIBROSIS/PROGRESSIVE PULMONARY FIBROSIS

Phase 1 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control

Last updated Jul 04, 2026 00:00 UTC

Idiopathic pulmonary fibrosis/progressive pulmonary fibrosis

Get alerted when new Idiopathic pulmonary fibrosis/progressive pulmonary fibrosis trials appear

New oral drug HRS-9813 takes first step against scarred lungs